Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A patient developed hair loss after hepatitis C treatment with sofosbuvir and ribavirin.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Plasmacytoid dendritic cells, which overproduce IFN-α, may play a crucial role in starting alopecia areata, an autoimmune disease causing hair loss.

Topical rosuvastatin and melatonin creams significantly reduce psoriasis severity and are safe.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Laser treatment, especially when combined with other therapies, is effective for hair regrowth in alopecia areata.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

The document concludes that doctors should monitor children's brain development when treating hemangiomas with interferon alfa and consider stopping the treatment if problems arise, while also exploring drugs that might counteract side effects.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

Adding colchicine stopped the girl's recurring heart issues caused by lupus.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Pimecrolimus cream is not effective for treating alopecia areata.

N-acetyl-GED may help prevent and partially reverse a process that leads to scarring hair loss.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

CTE can distort results in hair growth trials, so exclude it carefully.

The combination therapy of PEG-IFN α-2a and Ribavirin can cause widespread hair loss and skin reactions.

Adalimumab may cause severe hair loss in some patients.

IL-24 contributes to skin aging by increasing collagen-degrading enzymes and decreasing collagen production when exposed to air pollution.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.